HELLINGHAUSEN ET AL.
11
2. Boehm RE, Martire DE, Armstrong DW. Theoretical
considerations concerning the separation of enantiomeric
solutes by liquid chromatography. Anal Chem. 1988;60(6):
522‐528.
16. Zhang X, Bao Y, Huang K, Barnett‐Rundlett K, Armstrong DW.
Evaluation of dalbavancin as chiral selector for HPLC and com-
parison with teicoplanin‐based chiral stationary phases.
Chirality. 2010;22(5):495‐513.
3. Beesley TE. Description and evaluation of chiral interactive sites
on bonded chiral stationary phases for liquid chromatography.
In: Berthod A, ed. Chiral recognition in separation methods, Hei-
delberg. Germany: Springer; 2010:53‐76.
17. Armstrong DW, Liu Y, Ekborg‐Ott KH. A covalently bonded
teicoplanin chiral stationary phase for HPLC enantiose-
parations. Chirality. 1995;7(6):474‐497.
18. Dolzan MD, Shu Y, Smuts JP, et al. Enantiomeric separation of
citalopram analogues by HPLC using macrocyclic glycopeptide
and cyclodextrin based chiral stationary phases. J Liq Chromatog
Rel Technol. 2016;39(3):154‐160.
4. Xiao TL, Rozhtov RV, Larock RC, Armstrong DW. Separation of
the enantiomers of substituted dihydrofurocoumarins by HPLC
using macrocyclic glycopeptides CSPs. Anal Bioanal Chem.
2003;377(4):639‐654.
19. Liu Y, Berthod A, Mitchell CR, Xiao TL, Zhang B, Armstrong
DW. Super/subcritical fluid chromatography chiral separations
with macrocyclic glycopeptide stationary phases. J Chromatogr
A. 2002;978(1‐2):185‐204.
5. Gasper MP, Berthod A, Nair UB, Armstrong DW. Comparison
and modeling study of vancomycin, ristocetin A, and
teicoplanin for CE enantioseparations. Anal Chem.
1996;68(15):2501‐2514.
20. Beesley TE, Lee JT. Method development strategy and
applications update for CHIROBIOTIC chiral stationary
6. Berthod A, Qiu HX, Staroverov SM, Kuznestov MA, Armstrong
DW. Chiral recognition with macrocyclic glycopeptides:
mechanisms and applications. In: Berthod A, ed. Chiral
phases.
J
Liq Chromatog Rel Technol. 2009;32(11‐12):
1733‐1767.
recognition in separation methods, Heidelberg.
Springer; 2010:203‐222.
Germany:
21. Hellinghausen G, Lee JT, Weatherly CA, Lopez DA, Armstrong
DW. Evaluation of nicotine in tobacco‐free‐nicotine commercial
products. Drug Test Anal. 2017;9(6):944‐948.
7. Ekborg‐Ott KH, Kullman JP, Wang X, Gahm K, He L, Arm-
strong DW. Evaluation of the macrocyclic antibiotic
22. Hellinghausen G, Roy D, Wang Y, et al. A comprehensive meth-
odology for the chiral separation of 40 tobacco alkaloids and
their carcinogenic E/Z‐(R,S)‐tobacco specific nitrosamine
metabolites. Talanta. 2018;181:132‐141.
avoparcin as
a new chiral selector for HPLC. Chirality.
1998;10(7):627‐660.
8. Chen S, Liu Y, Armstrong DW, Borell JI, Martinez‐Terpel B,
Matallama JL. Enantioresolution of substituted 2‐methoxy‐6‐
oxo‐tetrahydropyridine‐3‐carbonitriles on macrocyclic antibiotic
and cyclodextrin stationary phases. J Liq Chromatog Rel Technol.
1995;18(8):1495‐1507.
23. Hellinghausen G, Roy D, Lee JT, et al. Effective methodolo-
gies for enantiomeric separations of 150 pharmacology and
toxicology related 1°, 2°, and 3° amines with core‐shell
chiral stationary phases.
J Pharm Biomed Anal. 2018;
9. Peter A, Vѐkes E, Armstrong DW. Effects of temperature on
retention of chiral compounds on a ristocetin A chiral stationary
phase. J Chrom a. 2002;958(1‐2):89‐107.
155:70‐81.
24. Barhate CL, Breitbach ZS, Costa Pinto E, Regalado EL, Welch
CJ, Armstrong DW. Ultrafast separation of fluorinated and
desfluorinated pharmaceuticals using chiral selectors bonded
to superficially porous particles. J Chromatogr A. 2015;1426:
241‐247.
10. Karlsson C, Karlsson L, Armstrong DW, Owens PK. Evaluation
of
a
vancomycin chiral stationary phase in capillary
electrochromatography using polar organic and reversed‐phase
modes. Anal Chem. 2000;72(18):4394‐4401.
25. Barhate CL, Wahab MF, Breitbach ZS, Bell DS, Armstrong DW.
High efficiency, narrow particle size distribution, sub‐2 μm
based macrocyclic glycopeptide chiral stationary phases in
HPLC and SFC. Anal Chim Acta. 2015;898:128‐137.
11. Rundlett KL, Gasper MP, Zhou EY, Armstrong DW. Capillary
electrophoretic enantiomeric separations using the glycopeptide
antibiotic, teicoplanin. Chirality. 1996;8(1):88‐107.
12. Maier V, Ranc V, Švidrnoch M, et al. Study on the use of
boromycin as a chiral selector in capillary electrophoresis.
J Chromatogr A. 2012;1237:128‐132.
26. Patel DC, Breitbach ZS, Wahab MF, Barhate CL, Armstrong
DW. Gone in seconds: praxis, performance, and peculiarities of
ultrafast chiral liquid chromatography with superficially porous
particles. Anal Chem. 2015;87(18):9137‐9148.
13. Berthod A, Yu T, Kullman JP, Armstrong DW. Evaluation of the
macrocyclic glycopeptide A‐40,926 as a high‐performance liquid
chromatographic chiral selector and comparison with
27. Patel DC, Wahab MF, Armstrong DW, Breitbach ZS. Advances
in high‐throughput and high‐efficiency chiral liquid chromato-
graphic separations. J Chromatogr A. 2016;1467:2‐18.
teicoplanin chiral stationary phase.
J
Chromatogr A.
2000;897(1‐2):113‐129.
28. Barhate CL, Joyce LA, Makarov AA, et al. Ultrafast chiral sepa-
rations for high throughput enantiopurity analysis. Chem
Commun. 2016;53:509‐512.
14. Berthod A, Nair UB, Bagwill C, Armstrong DW. Derivatized
vancomycin stationary phases for LC chiral separations.
Talanta. 1996;43(10):1767‐1782.
29. Spudeit DA, Dolzan MD, Breitbach ZS, Barber WE, Micke GA,
Armstrong DW. Superficially porous particles vs. fully porous
particles for bonded high performance liquid chromatographic
chiral stationary phases: isopropyl cyclofructan 6. J Chromatogr
A. 2014;1363:89‐95.
15. Xiao TL, Tesarova E, Anderson JL, Egger M, Armstrong DW.
Evaluation and comparison of a methylated teicoplanin agly-
cone to teicoplanin aglycone and natural teicoplanin chiral
stationary phases. J Sep Sci. 2006;29(3):429‐445.